Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Accepted: 19 April 2023
First Online: 10 June 2023
Compliance with Ethical Standards
:
: Alexandra Rezazadeh declares that she has no conflict of interest. Michael Deininger declares that he has no conflict of interest. Ehab Atallah has consulted for BMS, Abbvie, Takeda, and Novartis, is a speaker for BMS and Abbvie, and has participated on an advisory board for Takeda.
: This article does not contain any studies with human or animal subjects performed by any of the authors.
